- Home
- VALN vs NPFD Comparison
VALN vs NPFD Comparison
Compare VALN & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- NPFD
- Stock Information
- Founded
- VALN 2012
- NPFD 2021
- Country
- VALN France
- NPFD United States
- Employees
- VALN N/A
- NPFD N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- NPFD Trusts Except Educational Religious and Charitable
- Sector
- VALN Health Care
- NPFD Finance
- Exchange
- VALN Nasdaq
- NPFD Nasdaq
- Market Cap
- VALN 510.7M
- NPFD 455.0M
- IPO Year
- VALN 2021
- NPFD N/A
- Fundamental
- Price
- VALN $6.28
- NPFD $18.97
- Analyst Decision
- VALN Strong Buy
- NPFD
- Analyst Count
- VALN 3
- NPFD 0
- Target Price
- VALN $15.33
- NPFD N/A
- AVG Volume (30 Days)
- VALN 83.3K
- NPFD 64.7K
- Earning Date
- VALN 05-07-2025
- NPFD 01-01-0001
- Dividend Yield
- VALN N/A
- NPFD 6.28%
- EPS Growth
- VALN N/A
- NPFD N/A
- EPS
- VALN N/A
- NPFD N/A
- Revenue
- VALN $201,099,222.00
- NPFD N/A
- Revenue This Year
- VALN $18.74
- NPFD N/A
- Revenue Next Year
- VALN $29.26
- NPFD N/A
- P/E Ratio
- VALN N/A
- NPFD N/A
- Revenue Growth
- VALN 21.64
- NPFD N/A
- 52 Week Low
- VALN $3.62
- NPFD $14.50
- 52 Week High
- VALN $9.50
- NPFD $18.07
- Technical
- Relative Strength Index (RSI)
- VALN 47.26
- NPFD 56.47
- Support Level
- VALN $6.18
- NPFD $18.43
- Resistance Level
- VALN $6.54
- NPFD $19.17
- Average True Range (ATR)
- VALN 0.18
- NPFD 0.18
- MACD
- VALN 0.02
- NPFD -0.02
- Stochastic Oscillator
- VALN 45.65
- NPFD 56.76
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.